跳至主要内容
临床试验/NCT07176936
NCT07176936尚未招募不适用

Noninvasive Vagus Nerve Stimulation for Improved Speech in Noise Perception

University of Florida1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2026年1月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
55
试验地点
1
主要终点
Safety and feasibility

研究概览

简要总结

Traumatic brain injury, a common injury in military service personnel, often leads to poor processing of speech in noisy environments. The goal of the current study is to better understand the brain basis for this difficulty and evaluate a new approach to improving speech in noise perception.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •25-55 years old
  • •Proficiency in English
  • •TBI group: history of traumatic brain injury by blast or physical trauma
  • •Normal hearing group: no history of traumatic brain injury

排除标准

  • •Other neurological diseases or related conditions will be excluded (e.g., large vessel stroke, seizures). We will exclude patients with severe medical diseases that may be associated with impaired cognition (e.g., heart failure, dialysis dependent kidney disease, brain cancer). Further, psychiatric diseases that are unlikely to be related to trauma will be excluded (e.g., schizophrenia).
  • •Patients with histories of severe psychiatric disease prior to trauma exposure will be excluded.
  • •Current illicit or prescription drug abuse (within the last two months)
  • •Any taVNS contraindication, including but not limited to the presence of unremovable metal in the left ear, known heart conditions, medications that influence neurotransmitters thought to be critical for vagus nerve stimulation (norepinephrine, acetylcholine, and serotonin), or implanted medical devices such as a pacemaker.

研究组 & 干预措施

Treatment A vs Treatment B

Other

Participants will receive the stimulation at location A and then receive stimulation at location B, both on the outer ear.

干预措施: Cymba Conchae stimulation (Device)

Treatment A vs Treatment B

Other

Participants will receive the stimulation at location A and then receive stimulation at location B, both on the outer ear.

干预措施: Earlobe stimulation (Device)

Treatment B then Treatment A

Other

Participants will receive the stimulation at location B and then receive stimulation at location A, both on the outer ear.

干预措施: Cymba Conchae stimulation (Device)

Treatment B then Treatment A

Other

Participants will receive the stimulation at location B and then receive stimulation at location A, both on the outer ear.

干预措施: Earlobe stimulation (Device)

结局指标

主要结局

Safety and feasibility

时间窗: From enrollment to the end of treatment is between 2 days and 2 weeks.

quantify attrition as well as frequency and severity of adverse events

次要结局

  • Speech in Noise performance(Baseline and one week)
  • Brain response patterns(Baseline and one week)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验